Journal of Alternative Complementary & Integrative Medicine Category: Medicine Type: Short Commentary

Commentary on Jia-Ying Yuan et al.: Research Progress on Icariin, a Traditional Chinese Medicine Extract, in the Treatment of Asthma

Kai Yu1 and Jia-Yi Zhao1*
1 Department of general practice, The First Affiliated Hospital of Naval Medical University (Second Military Medical University), Shanghai, China

*Corresponding Author(s):
Jia-Yi Zhao
Department Of General Practice, The First Affiliated Hospital Of Naval Medical University (Second Military Medical University), Shanghai, China
Tel:+86 02131161551,

Received Date: Jan 26, 2022
Accepted Date: Feb 07, 2022
Published Date: Feb 14, 2022


I am delighted to have the opportunity to comment on the article, “Research progress on icariin, a traditional Chinese medicine extract, in the treatment of asthma "by Jia-Ying Yuan et al. Current asthma management guidelines recommend inhaled glucocorticoids as preferred therapy for control of mild persistent, moderate and severe asthma, according to the Global Initiative for Asthma (GINA) guidelines [1]. However, hormonal imbalance can lead to several health issues such as obesity, cardiovascular disease, autoimmune disease, breast cancer, and osteoporosis.It is an important research direction to find new, safe and effective drugs to replace hormones in the treatment of asthma.Traditional Chinese medicines and natural medicine are getting more attention, since Tu Youyou was awarded the 2015 Nobel Prize in physiology or medicine for the discovery of artemisinin used for malaria treatment. Epimedium for the treatment of asthma has been proposed in various traditional Chinese medicine prescriptions. Epimedium herb, commonly named as Yinyanghuo in Chinese, has its origins in the Berberidaceae family which include Epimedium koreanum Nakai, Epimedium brevicornum Maxim, Epimedium pubescens Maxim and Epimedium sagittatum. Icariin is a major bioactive component extracted from Epimediumbrevicornum Maxim, which has various biological attributessuch as anti-inflammatory and antioxidative activities, and immune regulation. 

As we all know, the pathogenesis of asthma is complex. Airway inflammation and airway remodeling are the main characteristics of asthma.Through a large number of literature collection, the author found that icariin mainly treats asthma through the following mechanisms:One ofthe mechanismis that Icariin could inhibit airway inflammation by regulating the expression of eosinophils and basophils and the Hypothalamic–Pituitary–Adrenal Axis (HPAA), improving the imbalance of Th1/Th2 cell and Th17/Treg cells and inhibiting the expression of Prostaglandin D2 (PGD2) and Endoplasmic Reticulum (ER) stress. The other mechanism is thatIcariin could inhibit airway remodeling byinhibiting extracellular matrix (ECM) deposition, airway epithelial cell-to-Mesenchymal Transition (EMT), airway smooth muscle (ASMC) proliferation and the proinflammatory effect of macrophages. There are many mechanisms of icariin in the treatment of asthma, butwhich mechanism is the most important is still worth further study. 

Icariin has attracted extensive attention in clinical treatment because of its extensive role.In this article, the author proposes that icariin has been found in many articles to have a variety of functions and is widely used in the treatment of various diseases,including lung cancer, heart disease, osteoporosis, and rheumatism [2-5]. It also can be used for the treatment of rheumatism and amelioration of neurological deficts [6,7]. Whether icariin will become a panacea like aspirin, or will it be combined with other traditional Chinese medicine to have many therapeutic effects on other diseases, which is also worthy of in-depth exploration and research.


  1. Global Strategy for Asthma Management and Prevention (2019) Global Initiative for Asthma 2018 GINA Report. Global Strategy for Asthma Management and Prevention, USA.
  2. Wu X, Kong W, Qi X, Wang S, Chen Y, et al. (2019) Icariin induces apoptosis of human lung adenocarcinoma cells by activating the mitochondrial apoptotic pathway. Life Sci 239: 116879.
  3. Qi C, Shao Y, Liu X, Wang D, Li X (2019) The cardioprotective effects of icariin on the isoprenaline-induced takotsubo-like rat model: involvement of reactive oxygen species and the TLR4/NF-κB signaling pathway. IntImmunopharmacol 74: 105733.
  4. Liu H, Li W, Luo B, Chen X, Wen W, et al. (2017) Icariin immobilized electrospinning poly(l-lactide) fibrous membranes via polydopamine adhesive coating with enhanced cytocompatibility and osteogenic activity. Mater Sci Eng C Mater Biol Appl 79: 399-409.
  5. Ye Y, Jing X, Li N, Wu Y, Li B, et al. (2017) Icariin promotes proliferation and osteogenic differentiation of rat adipose-derived stem cells by activating the RhoA-TAZ signaling pathway. Biomed. Pharmacother 88: 384-394.
  6. Peng T, Jiang Y, Farhan M, Lazarovici P, Chen L, et al. (2019) Anti-inflammatory Effects of Traditional Chinese Medicines on Preclinical in vivo Models of Brain Ischemia-Reperfusion-Injury: Prospects for Neuroprotective Drug Discovery and Therapy. Front Pharmacol 7: 10:204.
  7. Lin HM, Lin LF, Sun MY, Liu J, Wu Q (2020) Topical Delivery of Four Neuroprotective Ingredients by Ethosome-Gel: Synergistic Combination for Treatment of Oxaliplatin-Induced Peripheral Neuropathy. Int J Nanomedicine 15: 3251-3266.

Citation: Yu K, Zhao J-Y (2022) Commentary on Jia-Ying Yuan et al.: Research Progress on Icariin, a Traditional Chinese Medicine Extract, in the Treatment of Asthma. J Altern Complement Integr Med 8: 223.

Copyright: © 2022  Kai Yu, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Herald Scholarly Open Access is a leading, internationally publishing house in the fields of Sciences. Our mission is to provide an access to knowledge globally.

© 2023, Copyrights Herald Scholarly Open Access. All Rights Reserved!